2 Biotech Stocks With Major Incoming Catalysts
Over the past three months, the Nasdaq Biotechnology index has risen around 41%, thanks largely to the hordes of investors turning their attention to shares of companies with potential coronavirus treatments and vaccines in development.
This pandemic-driven frenzy for drugmaker stocks has made it awfully hard for investors who like to focus on the fundamentals. Luckily, companies such as Acadia Pharmaceuticals (NASDAQ: ACAD) Y-mAbs (NASDAQ: YMAB) have major catalysts unrelated to COVID-19 in their near term future.
Image source: Getty Images.
Source Fool.com


